A detailed history of Ubs Group Ag transactions in Nevro Corp stock. As of the latest transaction made, Ubs Group Ag holds 9,581 shares of NVRO stock, worth $36,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,581
Previous 14,003 31.58%
Holding current value
$36,311
Previous $117,000 54.7%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.71 - $10.1 $20,827 - $44,662
-4,422 Reduced 31.58%
9,581 $53,000
Q2 2024

Aug 13, 2024

SELL
$7.96 - $13.59 $199,047 - $339,831
-25,006 Reduced 64.1%
14,003 $117,000
Q1 2024

May 13, 2024

BUY
$13.56 - $20.78 $410,962 - $629,779
30,307 Added 348.28%
39,009 $563,000
Q4 2023

Feb 09, 2024

SELL
$14.18 - $22.31 $12.7 Million - $20 Million
-894,570 Reduced 99.04%
8,702 $187,000
Q3 2023

Nov 09, 2023

BUY
$18.22 - $25.85 $16.4 Million - $23.2 Million
898,629 Added 19354.49%
903,272 $17.4 Million
Q2 2023

Aug 11, 2023

SELL
$22.62 - $39.32 $74,872 - $130,149
-3,310 Reduced 41.62%
4,643 $118,000
Q1 2023

May 12, 2023

BUY
$30.17 - $41.11 $203,164 - $276,834
6,734 Added 552.42%
7,953 $287,000
Q4 2022

Feb 08, 2023

BUY
$36.43 - $49.4 $29,909 - $40,557
821 Added 206.28%
1,219 $48,000
Q3 2022

Nov 10, 2022

SELL
$40.66 - $53.03 $15,898 - $20,734
-391 Reduced 49.56%
398 $19,000
Q2 2022

Aug 10, 2022

BUY
$40.85 - $77.67 $4,779 - $9,087
117 Added 17.41%
789 $35,000
Q1 2022

May 16, 2022

SELL
$59.95 - $92.06 $1,858 - $2,853
-31 Reduced 4.41%
672 $48,000
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $3,323 - $4,972
41 Added 6.19%
703 $57,000
Q3 2021

Nov 15, 2021

BUY
$101.99 - $166.36 $407 - $665
4 Added 0.61%
662 $77,000
Q2 2021

Aug 13, 2021

SELL
$141.6 - $179.06 $602,649 - $762,079
-4,256 Reduced 86.61%
658 $109,000
Q1 2021

May 12, 2021

BUY
$132.81 - $182.18 $150,075 - $205,863
1,130 Added 29.86%
4,914 $685,000
Q4 2020

Feb 11, 2021

BUY
$138.17 - $184.34 $204,491 - $272,823
1,480 Added 64.24%
3,784 $655,000
Q3 2020

Nov 12, 2020

BUY
$114.09 - $145.51 $204,221 - $260,462
1,790 Added 348.25%
2,304 $321,000
Q2 2020

Jul 31, 2020

SELL
$89.45 - $129.85 $23,257 - $33,761
-260 Reduced 33.59%
514 $61,000
Q1 2020

May 01, 2020

SELL
$70.23 - $144.31 $274,880 - $564,829
-3,914 Reduced 83.49%
774 $77,000
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $137,614 - $211,689
-1,801 Reduced 27.75%
4,688 $551,000
Q3 2019

Nov 14, 2019

BUY
$61.52 - $91.1 $3,445 - $5,101
56 Added 0.87%
6,489 $558,000
Q2 2019

Aug 14, 2019

SELL
$58.04 - $66.99 $240,285 - $277,338
-4,140 Reduced 39.16%
6,433 $417,000
Q1 2019

May 14, 2019

BUY
$35.52 - $62.62 $225,232 - $397,073
6,341 Added 149.83%
10,573 $661,000
Q4 2018

Feb 14, 2019

SELL
$35.43 - $56.29 $25,828 - $41,035
-729 Reduced 14.69%
4,232 $164,000
Q3 2018

Nov 14, 2018

SELL
$44.22 - $75.47 $16,980 - $28,980
-384 Reduced 7.18%
4,961 $283,000
Q2 2018

Aug 14, 2018

SELL
$72.38 - $92.5 $9,698 - $12,395
-134 Reduced 2.45%
5,345 $427,000
Q1 2018

May 15, 2018

BUY
$69.46 - $88.57 $104,815 - $133,652
1,509 Added 38.01%
5,479 $474,000
Q4 2017

Feb 14, 2018

SELL
$65.94 - $93.31 $126,011 - $178,315
-1,911 Reduced 32.49%
3,970 $274,000
Q3 2017

Nov 14, 2017

SELL
$80.87 - $91.08 $2.7 Million - $3.04 Million
-33,373 Reduced 85.02%
5,881 $534,000
Q2 2017

Aug 14, 2017

BUY
N/A
17,409 Added 79.69%
39,254 $2.92 Million
Q1 2017

Nov 14, 2017

BUY
N/A
21,845
21,845 $2.05 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $134M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.